C4 Therapeutics (CCCC) FCF Margin Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 5,389.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,525.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -341.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 43,511.00 |
| 10 | C4 Therapeutics | 561.03 Mn | 325.36 Mn | - | -2,749.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,749.00 |
| Dec 31, 2025 | 14,518.00 |
| Sep 30, 2025 | -12,237.00 |
| Jun 30, 2025 | -14,957.00 |
| Mar 31, 2025 | 13,632.00 |
| Dec 31, 2024 | 34,294.00 |
| Sep 30, 2024 | 13,112.00 |
| Jun 30, 2024 | 67,258.00 |
| Mar 31, 2024 | 29,025.00 |
| Dec 31, 2023 | 29,696.00 |
| Sep 30, 2023 | 9,866.00 |
| Jun 30, 2023 | -53,128.00 |
| Mar 31, 2023 | -53,671.00 |
| Dec 31, 2022 | -85,780.00 |
| Sep 30, 2022 | -17,202.00 |
| Jun 30, 2022 | 886.00 |
| Mar 31, 2022 | -829.00 |
| Dec 31, 2021 | 14,070.00 |
| Sep 30, 2021 | -4,632.00 |
| Jun 30, 2021 | -4,012.00 |
| Mar 31, 2021 | -9,675.00 |
| Dec 31, 2020 | -12,834.00 |